These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10463232)

  • 1. [Piracetam in severe cranio-cerebral injuries].
    Gościński I; Sliwonik S; Sondej T; Kwiatkowski S; Moskała M; Cichoński J; Wegrzyn D; Uhl H
    Neurol Neurochir Pol; 1998; 32(5):1189-97. PubMed ID: 10463232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical observations concerning piracetam treatment of patients after craniocerebral injury].
    Gościński I; Moskała M; Cichoński J; Polak J; Krupa M; Sliwonik S; Sondej T
    Przegl Lek; 1999; 56(2):119-20. PubMed ID: 10375942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents].
    Zavadenko NN; Guzilova LS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):43-8. PubMed ID: 18427539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group.
    Ikeda A; Shibasaki H; Tashiro K; Mizuno Y; Kimura J
    Mov Disord; 1996 Nov; 11(6):691-700. PubMed ID: 8914096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sudden hearing loss. Treatment with piracetam].
    Solanellas Soler J; Esteban Ortega F; Soldado Patiño L; Jiménez Morales JM
    Acta Otorrinolaringol Esp; 1997; 48(1):21-5. PubMed ID: 9131921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of pharmacological treatment in the compensation of vertigo].
    Pons Rocher F
    An Otorrinolaringol Ibero Am; 1999; 26(3):271-91. PubMed ID: 10394686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of piracetam on ataxia: clinical observations in a group of autosomal dominant cerebellar ataxia patients.
    Ince Gunal D; Agan K; Afsar N; Borucu D; Us O
    J Clin Pharm Ther; 2008 Apr; 33(2):175-8. PubMed ID: 18315783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Porównanie skuteczności piracetamu i dekstranu 40 tys. u chorych w podeszlym wieku z niedokrwiennym udarem mózgu].
    Kozubski W
    Wiad Lek; 1998; 51(7-8):321-5. PubMed ID: 9748886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
    Güngör L; Terzi M; Onar MK
    Brain Lang; 2011 Apr; 117(1):23-7. PubMed ID: 21227483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents.
    Zavadenko NN; Guzilova LS
    Neurosci Behav Physiol; 2009 May; 39(4):323-8. PubMed ID: 19340573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative evaluation of the neuroprotective activity of phenotropil and piracetam in laboratory animals with experimental cerebral ischemia].
    Tiurenkov IN; Bagmetov MN; Epishina VV
    Eksp Klin Farmakol; 2007; 70(2):24-9. PubMed ID: 17523446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiological rationale for the use of piracetam in sudden deafness].
    García Callejo FJ; Velert Vila MM; Morant Ventura A; Orts Alborch MH; Marco Algarra J; Blay Galaud L
    Acta Otorrinolaringol Esp; 2000 May; 51(4):319-26. PubMed ID: 10984955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of piracetam on the functional activity of the brain in patients with craniocerebral injuries].
    Sharova EV; Potapov AA; Kulikov MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(5):42-8. PubMed ID: 3137753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nizofenone on experimental head trauma in mice.
    Hayashi Y; Shimada O; Yasuda H; Ikegami K
    Arch Int Pharmacodyn Ther; 1994; 328(3):251-60. PubMed ID: 7625881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of piracetam in vertigo.
    Oosterveld WJ
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():54-60. PubMed ID: 10338110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palatal tremor in childhood: clinical and therapeutic considerations.
    Campistol-Plana J; Majumdar A; Fernández-Alvarez E
    Dev Med Child Neurol; 2006 Dec; 48(12):982-4. PubMed ID: 17109787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of piracetam on cognitive performance in patients undergoing bypass surgery.
    Uebelhack R; Vohs K; Zytowski M; Schewe HJ; Koch C; Konertz W
    Pharmacopsychiatry; 2003 May; 36(3):89-93. PubMed ID: 12806565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of nootropic agents on the brain bioelectrical activity and on the indices of neuromediator metabolism in the acute period of severe craniocerebral trauma].
    Madorskiĭ SV; Potapov AA; Piasetskaia MV; Shapova EV; Il'icheva RF
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (3):29-35. PubMed ID: 2572097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined treatment supported by piracetam and/or acyclovir in idiopathic sudden sensorineural hearing loss: experience with 81 cases].
    Karakurt SE; Ozkul MD; Cukurova I; Demirhan E; Yiğitbaşi OG
    Kulak Burun Bogaz Ihtis Derg; 2009; 19(1):22-7. PubMed ID: 19793043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury.
    Zou H; Brayer SW; Hurwitz M; Niyonkuru C; Fowler LE; Wagner AK
    Neurorehabil Neural Repair; 2013; 27(9):878-88. PubMed ID: 23812605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.